However, IL-6 levels have been reported to correlate significantly with other markers [130,133] of verified prognostic impact for MPM such as VEGF [145,146,147], thrombocytosis [107,111,142] and CRP levels [11,116,142]. The gene discussed is IL6; the disease is thrombocytosis disease.